mRNA-based therapy proves superior to the standard of care for treating hereditary tyrosinemia 1 in a mouse model - Cacicedo, Maximiliano L.; Weinl-Tenbruck, Christine; Frank, Daniel; Wirsching, Sebastian; Straub, Beate Katharina; Hauke, Jana; Okun, Jürgen G.; Horscroft, Nigel; Hennermann, Julia B.; Zepp, Fred; Chevessier-Tünnesen, Frédéric; Gehring, Stephan (Molecular therapy. Methods & clinical development, 2022)
Gesehen am 13.02.2023